Search

Author/Creator Bais, Carlos

1. Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation. (January 2017)

Authors:
Miles, David; Cameron, David; Bondarenko, Igor; Manzyuk, Lyudmila; Alcedo, Juan Carlos; Lopez, Roberto Ivan; Im, Seock-Ah; Canon, Jean-Luc; Shparyk, Yaroslav; Yardley, Denise A.; Masuda, Norikazu; Ro, Jungsil; Denduluri, Neelima; Hubeaux, Stanislas; Quah, Cheng; Bais, Carlos; O'Shaughnessy, Joyce
Journal:
European journal of cancer
Issue:
Volume 70(2017)
Page Start:
146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Development of a gene expression–based prognostic signature for IDH wild-type glioblastoma. Issue 12 (8th September 2020)

Authors:
Johnson, Radia M; Phillips, Heidi S; Bais, Carlos; Brennan, Cameron W; Cloughesy, Timothy F; Daemen, Anneleen; Herrlinger, Ulrich; Jenkins, Robert B; Lai, Albert; Mancao, Christoph; Weller, Michael; Wick, Wolfgang; Bourgon, Richard; Garcia, Josep
Journal:
Neuro-oncology
Issue:
Volume 22:Issue 12(2020)
Page Start:
1742
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search